1 Torre LA,Bray FI,Siegel RL,et al.Global cancer statistics,2012. CA Cancer J Clin,2015,65:87-108. 2 Stolnicus S,Barsan I,Hoang L,et al.International endocervical adenocarcinoma criteria and classification(iecc):a new pathogenetic classification for invasive adenocarcinomas of the endocervix.Am J Surg Pathol,2018,42:214-226. 3 kokawa K,Takekida S,Kamiura S,et al.The incidence,treatment and prognosis of cervical carcinoma in young women:a retrospective analysis of 4975 cases in Japan.Eur J Gynaecol Oncol,2010,31:37-43. 4 陈凯锐,童华生,等.基于数据挖掘分析GALNT2在肺腺癌中的表达及预后意义.解放军医学杂志,2021,07:1-14. 5 Travaglino A,Raffone A,Gencarelli A.et al.TCGA classification of endometrial cancer:the place of carcinosarcoma.Pathol Oncol Res,2020,10:2067-2073. 6 Qiu JJ,Zhang XD,Tang XY,et al.ElncRNA1,a long non-coding RNA that is transcriptionally induced by oestrogen,promotes epithelial ovarian cancer cell proliferation.Int J Oncol,2017 51:507-514. 7 张倩雯,龚云辉,何跃东.HMGN2、CyclinD1在宫颈癌中的表达及临床意义.四川大学学报(医学版),2019,50:580-582. 8 周密,罗祥力,冯露.Beclin1,EGFR,cyclinD1在新辅助化疗宫颈癌组织中的表达及临床意义.标记免疫分析与临床,2020,27:235-240. 9 Sarkisian S,Davar D.MEK inhibitors for the treatment of NRAS mutant melanoma.Drug Des Devel Ther,2018,12:2553-2565. 10 韦荣飞,李梦媛,杨星九,等.Smad3对非小细胞肺癌A549细胞核宫颈癌Hela细胞迁移的影响.中国比较医学杂志,2017,27:11-15. 11 Haiyan Zhu,Hui Luo,Zhaojun Shen,et al.Transforming growth factor-β1 in carcinogenesis,progression,and therapy in cervical cancer.Tumour Biol,2016,37:7075-7083. 12 陈凤霞.宫颈癌病情进展过程中PI3K/AKT/mTOR信号通路的变化及靶基因的探究.海南医学院学报,2018,24:1757-1760. 13 刘兰,杨莎莎,陈海月,等.宫颈癌组织中Ki67与EBP1表达变化及意义.山东医药,2016,56:78-79. 14 王文慧,邵志叶,陈豪.宫颈癌组织中Hippo-Yes相关蛋白1的表达及临床意义.中国现代医学杂志,2020,30:27-32. 15 Lochhead PA,Clark J,Wang LZ,et al.Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7amplification are not addicted to ERK5 activity for cell proliferation.Cell Cycle,2016,15:506-518. 16 Liang M,Zhao J.Protein expression of AIB1,p53 and Bcl-2 in epithelial ovarian cancer and their correlations with the clinical pathological features and prognosis.Eur Rev Med Pharmacol Sci,2018,22:5134-5139. 17 Shukla S,Dass J,Pujani M.p53 and bcl-2 expression in malignant and premalignant lesions of uterine cervix and their correlation with human papilloma virus 16 and 18. South Asian J Cancer,2014,3:48-53.